CoV-19/SARS-CoV-2 is a highly pathogenic virus that causes coronavirus-19 disease (COVID-19) an acute respiratory distress syndrome which provokes serious problems for global health. Studies suggest that there are many differences between men and women in the immune response to CoV-19 infection and inflammatory diseases. Women, compared to men, are less susceptible to viral infections based on a different innate immunity, steroid hormones and factors related to sex chromosomes. The presence of two X chromosomes in women emphasize the immune system even if one is inactive. The immune regulatory genes encoded by X chromosome in female gender causes lower viral load levels, and less inflammation than in man, while CD4+ T cells are higher with better immune response. In addition, women generally produce higher levels of antibodies which remain in the circulation longer. The levels of activation of the immune cells are higher in women than in men, and it is correlated with the trigger of TLR7 and the production of IFN. TLR7 is higher in women than in men and its biallelic expression leads to higher immune responses and increases the resistance to viral infections. TLR7 is expressed in innate immune cells which recognizes single strand RNA virus by promoting the production of antibodies against the virus and the generation of pro-inflammatory cytokines including IL-6 and IL-1 family members. Moreover, in women the production of inflammatory IL-6 after viral infection is lower than in males and is often correlated with a better longevity. In addition, on the X chromosome there are loci that code for the genes involved in the regulation of immune cells such as FOXP3, and transcription factor for Treg involved in virus pathogenesis. The X chromosome influences the immune system by acting on many other proteins, including TLR8, CD40L and CXCR3 which can be over-expressed in women, and influence the response to viral infections and vaccinations. However, the biallelic expression of the X-linked genes can promote harmful autoimmune and inflammatory responses. Cardiovascular diseases are more frequent in males and subjects without cardiovascular dysfunctions infected by CoV-19 have a better prognosis, but these effects are still under study. It is hoped that certain drugs, such as CoV-19 receptor blockers, anti-inflammatories (against rheumatic diseases), monoclonal antibodies, anti-IL-1 and anti-IL-6, the remdesevir drug (analogue adenosine, effective against ebola), hydroxychloroquine (for the treatment of malaria) and vaccines, will open up new strategies and new therapeutic ways to combat this terrible virus.
Keywords: CoV-19; coronavirus 19; gender; immunity cytokine; virus.
Copyright 2020 Biolife Sas. www.biolifesas.org.
Coronavirus virulence genes with main focus on SARS-CoV envelope gene.Version 2. Virus Res. 2014 Dec 19;194:124-37. doi: 10.1016/j.virusres.2014.07.024. Epub 2014 Aug 2. Virus Res. 2014. PMID: 25093995 Free PMC article. Review.
How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.J Biol Regul Homeost Agents. 2020 Mar 31;34(2). doi: 10.23812/Editorial-Conti-2. Online ahead of print. J Biol Regul Homeost Agents. 2020. PMID: 32228825
The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection.mBio. 2016 Dec 13;7(6):e01721-16. doi: 10.1128/mBio.01721-16. mBio. 2016. PMID: 27965448 Free PMC article.
Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.J Gen Virol. 2013 Dec;94(Pt 12):2679-2690. doi: 10.1099/vir.0.055533-0. Epub 2013 Sep 28. J Gen Virol. 2013. PMID: 24077366
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2.Int J Biol Sci. 2020 Mar 15;16(10):1718-1723. doi: 10.7150/ijbs.45123. eCollection 2020. Int J Biol Sci. 2020. PMID: 32226289 Free PMC article. Review.
Cited by 3 articles
Impact of sex and gender on COVID-19 outcomes in Europe.Version 2. Biol Sex Differ. 2020 May 25;11(1):29. doi: 10.1186/s13293-020-00304-9. Biol Sex Differ. 2020. PMID: 32450906 Free PMC article. Review.
Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?Intern Emerg Med. 2020 May 9:1-8. doi: 10.1007/s11739-020-02355-7. Online ahead of print. Intern Emerg Med. 2020. PMID: 32385628 Free PMC article. Review.
Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D.Int J Mol Sci. 2020 Apr 22;21(8):2948. doi: 10.3390/ijms21082948. Int J Mol Sci. 2020. PMID: 32331343 Free PMC article.